Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02062801 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Ephedrine and Combined Spinal Epidurals for Labor
A Phase 4 study, sponsored by Sharp HealthCare.
- Completed
- Registry status
- Phase 4
- Development phase
- 710
- Enrollment target
NCT02062801: Completed Phase 4 study, sponsored by Sharp HealthCare.
NCT02062801 is a Phase 4 study that has completed, run by Sharp HealthCare. The registered enrollment target is 710 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02062801, a Phase 4 study, has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 710 participants
- Enrollment target
Study Summary
The combined spinal epidural (CSE) technique has become increasingly popular for labor pain because of its rapid onset and superior first stage analgesia. However, increased risk for early profound fetal bradycardia (EPFB) following CSE continues to be a concern. Various factors are implicated in the etiology of EPFB but the cause is unknown. Ephedrine administration prior to CSE analgesia may help reduce the risk of EPFB, but to date, nobody has studied the impact of a single dose of intravenous (IV) ephedrine given at the time of CSE administration during labor. The purpose of this study is to measure the incidence of EPFB after combined spinal epidural analgesia using standard definitions. The incidence of EPFB will be compared between patients who receive prophylactic ephedrine or placebo at the time of CSE placement.
Interventions
- DRUG Placebo
- DRUG Ephedrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 710 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02062801
The ClinicalTrials.gov registry entry for NCT02062801 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 710 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02062801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02062801 about?
NCT02062801 is a clinical study titled "Prophylactic Ephedrine and Combined Spinal Epidurals for Labor". The combined spinal epidural (CSE) technique has become increasingly popular for labor pain because of its rapid onset and superior first stage analgesia. However, increased risk for early profound fetal bradycardia (EPFB) following CSE continues to be a concern. Various factors are implicated in th...
What is the current status of trial NCT02062801?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 710 participants. The study started on 2012-01. Estimated completion is 2013-10.
What interventions are being tested in trial NCT02062801?
The interventions under investigation include: Placebo (DRUG), Ephedrine (DRUG).
Who is sponsoring clinical trial NCT02062801?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.